Development of FAP-Targeted Chimeric Antigen Receptor NK-92 Cells for Non-Small Cell Lung Cancer

Fang Yang(Anhui Provincial Hospital), Jimin Gao(Wenzhou Medical University)
Discovery Medicine
January 1, 2023
10.24976/discov.med.202335176.41
Cited by 25

Related Papers

Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expression
|Oncology Letters|2021|24
Combination of 4-1BB and DAP10 promotes proliferation and persistence of NKG2D(bbz) CAR-T cells
|Frontiers in Oncology|2022|12